allitem_id Publication Year Title Author(s) 1 Oct-2015 PET-based compartmental modeling of (124)I-A33 antibody: quantitative characterization of patient-specific tumor targeting in colorectal cancer. Zanzonico, Pat; Carrasquillo, Jorge A; Pandit-Taskar, Neeta; O'Donoghue, Joseph A; Humm, John L; Smith-Jones, Peter; Ruan, Shutian; Divgi, Chaitanya; Scott, Andrew M 2 22-Mar-2012 Antibody therapy of cancer. Scott, Andrew M 3 1-Dec-2007 Internalization, intracellular trafficking, and biodistribution of monoclonal antibody 806: a novel anti-epidermal growth factor receptor antibody. Perera, Rushika M; Zoncu, Roberto; Johns, Terrance G; Pypaert, Marc; Lee, Fook-Thean; Mellman, Ira; Old, Lloyd J; Toomre, Derek K; Scott, Andrew M 4 1-Jun-2007 A phase I biodistribution and pharmacokinetic trial of humanized monoclonal antibody Hu3s193 in patients with advanced epithelial cancers that express the Lewis-Y antigen. Scott, Andrew M 5 1-Sep-2005 Treatment of human tumor xenografts with monoclonal antibody 806 in combination with a prototypical epidermal growth factor receptor-specific antibody generates enhanced antitumor activity. Perera, Rushika M; Narita, Yoshitaka; Furnari, Frank B; Gan, Hui K 6 28-Mar-2005 Engineering and characterisation of chimeric monoclonal antibody 806 (ch806) for targeted immunotherapy of tumours expressing de2-7 EGFR or amplified EGFR. Panousis, C; Rayzman, V M; Johns, T G; Renner, C; Liu, Z; Cartwright, Glenn A; Lee, Fook-Thean; Wang, D; Gan, Hui K 7 17-Mar-2005 The antitumor monoclonal antibody 806 recognizes a high-mannose form of the EGF receptor that reaches the cell surface when cells over-express the receptor. Johns, Terrance G; Mellman, Ira; Cartwright, Glenn A; Ritter, Gerd; Old, Lloyd J; Burgess, Antony W; Scott, Andrew M 8 22-Feb-2005 Immunological effects of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanoma. Scott, Andrew M 9 2005 Recombinant NY-ESO-1 cancer antigen: production and purification under cGMP conditions. Murphy, R; Green, S; Ritter, G; Cohen, L; Ryan, D; Woods, W; Rubira, M; Cebon, Jonathan S 10 9-Apr-2004 Identification of the epitope for the epidermal growth factor receptor-specific monoclonal antibody 806 reveals that it preferentially recognizes an untethered form of the receptor. Johns, Terrance G; Adams, Timothy E; Cochran, Jennifer R; Hall, Nathan E; Hoyne, Peter A; Olsen, Mark J; Kim, Yong-Sung; Rothacker, Julie; Nice, Edouard C; Walker, Francesca; Ritter, Gerd; Jungbluth, Achim A; Old, Lloyd J; Ward, Colin W; Burgess, Antony W; Wittrup, K Dane; Scott, Andrew M 11 15-Dec-2003 Antitumor efficacy of cytotoxic drugs and the monoclonal antibody 806 is enhanced by the EGF receptor inhibitor AG1478. Johns, Terrance G; Luwor, Rodney B; Murone, Carmel 12 1-Aug-2003 Expression and targeting of human fibroblast activation protein in a human skin/severe combined immunodeficient mouse breast cancer xenograft model. Tahtis, Kiki; Lee, Fook-Thean; Wheatley, Jennifer M; Garin-Chesa, Pilar; Park, John E; Smyth, Fiona E; Obata, Yuichi; Stockert, Elisabeth; Hall, Cathrine M; Old, Lloyd J; Rettig, Wolfgang J; Scott, Andrew M 13 1-May-2003 A Phase I dose-escalation study of sibrotuzumab in patients with advanced or metastatic fibroblast activation protein-positive cancer. Scott, Andrew M 14 7-Oct-2002 Cytokine enhancement of in vitro antibody-dependent cellular cytotoxicity mediated by chimeric anti-GD3 monoclonal antibody KM871. Liu, Zhanqi; Lee, Fook-Thean; Hanai, Nobuo; Smyth, Fiona E; Burgess, Antony W; Old, Lloyd J; Scott, Andrew M 15 1-Oct-2001 Specific targeting, biodistribution, and lack of immunogenicity of chimeric anti-GD3 monoclonal antibody KM871 in patients with metastatic melanoma: results of a phase I trial. Scott, Andrew M 16 15-Jul-2001 Monoclonal antibody 806 inhibits the growth of tumor xenografts expressing either the de2-7 or amplified epidermal growth factor receptor (EGFR) but not wild-type EGFR. Luwor, R B; Johns, T G; Murone, Carmel 17 1-Jun-2001 Specific localization, gamma camera imaging, and intracellular trafficking of radiolabelled chimeric anti-G(D3) ganglioside monoclonal antibody KM871 in SK-MEL-28 melanoma xenografts. Lee, Fook-Thean; Rigopoulos, Angela; Hall, C; Clarke, K; Cody, S H; Smyth, Fiona E; Liu, Z; Brechbiel, Martin W; Hanai, N; Nice, Edouard C; Catimel, B; Burgess, Antony W; Welt, S; Ritter, G; Old, Lloyd J; Scott, Andrew M 18 1-May-2001 Immuno-PET of human colon xenograft- bearing BALB/c nude mice using 124I-CDR-grafted humanized A33 monoclonal antibody. Lee, Fook-Thean; Hall, C; Rigopoulos, Angela; Zweit, J; Pathmaraj, K 19 1-Apr-2001 Biodistribution properties of (111)indium-labeled C-functionalized trans-cyclohexyl diethylenetriaminepentaacetic acid humanized 3S193 diabody and F(ab')(2) constructs in a breast carcinoma xenograft model. Tahtis, K; Lee, Fook-Thean; Smyth, Fiona E; Power, David Anthony; Renner, C; Brechbiel, Martin W; Old, Lloyd J; Hudson, P J; Scott, Andrew M 20 1-Sep-2000 In vivo biodistribution of a humanized anti-Lewis Y monoclonal antibody (hu3S193) in MCF-7 xenografted BALB/c nude mice. Clarke, K; Lee, Fook-Thean; Brechbiel, Martin W; Smyth, Fiona E; Old, Lloyd J; Scott, Andrew M
Loading...
2
0
20
0
false
0000-0002-6656-295x
@ONJCRI